The rising interest in GLP-1 agonists for metabolic conditions has led to a debate about formats: transdermal systems versus pills . Typically, GLP-1 therapies were only available in oral form, but the https://elodierdgt875725.activablog.com/39967511/glp-1-patches-vs-oral-medications-which-right-for-the-patient